Soon after graduation, Tony Tam (PhD ’18) advances drug development and formulation at Merck.
Soon after graduation, Tony Tam (PhD ’18) advances drug development and formulation at Merck.
From biotech to the ongoing COVID-19 response, alum Mark Rogge (BS ’82, MS ’84) is leading the charge.
Professor Lingjun Li’s mass spectrometry expertise enables large-scale discovery of low-abundance neuropeptides with potential applications in medical and environmental challenges.